24/7 Market News Snapshot 05 May, 2025 – Rafael Holdings, Inc. Class B Common Stock (NYSE:RFL)

May 5, 2025

DENVER, Colo., 05 May, 2025 (www.247marketnews.com) – (NYSE:RFL) are discussed in this article.
Rafael Holdings, Inc. is witnessing a notable shift in its stock as the Class B Common Stock (RFL) opened today at $1.52 and has experienced a significant increase of 14.35%, currently trading at $1.761 with a robust trading volume of 780.63K shares. This upward momentum indicates growing investor confidence, suggesting a favorable market sentiment surrounding the company’s performance. As RFL surpasses its initial trading price, investors are encouraged to monitor support and resistance levels to leverage this bullish trend.

Amid this positive market activity, Rafael Holdings has announced a strategic rights offering designed to enhance shareholder value. Effective for all holders of record as of May 9, 2025, this initiative aims at increasing investor engagement in the company’s innovative projects. Under the proposed plan, shareholders will receive one non-transferable subscription right for each share held, enabling them to purchase 0.603 of a share of Class B Common Stock at a subscription price of $1.28 per share. The subscription period is scheduled to start on May 13, 2025, and conclude on May 29, 2025.

To reinforce shareholder confidence, Executive Chairman Howard Jonas will secure a Standby Purchase Agreement, guaranteeing that any unsold shares during the offering will be acquired, thereby aligning with the company’s commitment to promoting strategic growth and protecting stakeholder interests. Former holders of Cyclo Therapeutics, Inc. are specifically prompted to complete necessary exchanges promptly to establish their status as record holders of the Class B common stock before the Record Date.

Rafael Holdings is also enlisting D.F. King & Co., Inc. as its Information Agent for this offering, underscoring the company’s dedication to transparency and informed investor decision-making as it continues to pursue advancements in the pharmaceutical landscape.

Related news for (RFL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.